Sarepta Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SRPT and other ETFs, options, and stocks.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

CEO

Douglas S. Ingram

CEODouglas S. Ingram

Employees

1,372

Employees1,372

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

1980

Founded1980

Employees

1,372

Employees1,372

SRPT Key Statistics

Market cap

5.77B

Market cap5.77B

Price-Earnings ratio

25.37

Price-Earnings ratio25.37

Dividend yield

—

Dividend yield—

Average volume

2.50M

Average volume2.50M

High today

$62.65

High today$62.65

Low today

$59.06

Low today$59.06

Open price

$61.65

Open price$61.65

Volume

1.93M

Volume1.93M

52 Week high

$173.25

52 Week high$173.25

52 Week low

$48.01

52 Week low$48.01

SRPT News

Benzinga 3d

Netflix To Rally More Than 55%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please...

Simply Wall St 4d

Sarepta Therapeutics, Inc. Not Doing Enough For Some Investors As Its Shares Slump 27%

To the annoyance of some shareholders, Sarepta Therapeutics, Inc. ( ) shares are down a considerable 27% in the last month, which continues a horrid run for the...

Simply Wall St 6d

Exploring 3 High Growth Tech Stocks In The US Market

Over the last 7 days, the United States market has remained flat, yet it is up 5.7% over the past year with earnings forecasted to grow by 13% annually. In this...

Analyst ratings

84%

of 25 ratings

Buy

84%

Hold

16%

Sell